Mat 3 insider shares in March – are they still good in April? News ad

Buying insiders taken for Matador Resources (NYSE: MTDR), Tenaya Therapeutics (NASDAQ: TNYA) and FIRSTSUN Capital Bancorp (NASDAQ: FSUN) in March. These companies occupy high grades, if not in the first position, for the number of purchases of insiders, the number of shares purchased and the amount spent in dollars, respectively. The question is, what good buyers for investors and March are a good time to buy them?

Matorean resources insiders cannot stop buying

Matador Resources is an independent company for exploration and production of oil and gas operating in the United States. Insiderads are not used to, and its insiders bought it for many years. The occupation of March 2025 deserves attention, because the action remains high in the list, taking 1st place in the number of insiders buyers. Nine insiders, including general director, financial director, CAO, COO, EVP and directors, bought promotions from late February to the end of March.

Their activity also deserves attention for this volume, which set a long -term record by winning 1.1 million dollars. USA without complex sales. Insiders now own more than 6.1% of the shares and will continue to increase their assets over time.

Dividends are one of the reasons why insiders buy this action. The company is a solid payer of dividends, bringing about 2.45% with shares of about $ 52.50 and a distributor manufacturer. Over the past few years, the company has increased payment of every few quarters, increasing the payment by 1000% in four years, and it is expected that this trend will continue.

The payment coefficient is very low at 11% and can maintain an aggressive increase without business growth. Business growth is also good, works with solid double-digit rates within 2024 and it is predicted that over the next few years it supports high to low to dubes of the pace.

Insiders buy penny shares Tenaya Therapeutics

Tenaya Therapeutics occupies a high place in terms of the number of shares purchased by insiders, which is not surprising, given the price of this health care. This action of a penny is traded in less than $ 0.70 after many years of descending trend, offering the deep value of the entrance. The problem for investors is that the buyer is the main shareholder, and not the executive director of the company sold during the quarter. The main shareholder is a group of columns, a company of venture capital, focused on the science of life. He bought 35 million shares for almost $ 25 million, as a result of which the holding is more than 49 million or about 30% of the shares.

Tenia is focused on revolutionary methods of treating the heart. He uses a tripartite research approach aimed at genetic therapy, cell regeneration and accurate medicine. The company has several treatment methods in its pipeline and, as expected, will lead to positive test results in 2025. Seven analysts unanimously evaluate the action as a purchase and see that it comes out more than 1000% in the lower part of their target range. Institutions are also optimistic in this action, owning more than 90% and increasing their purchase to many years of maximum in the first quarter of 2025.

FIRSTSUN Capital Capital Bancorp Temport relies large bets

FIRSTSUN Capital Bancorp is a smaller regional bank operating in the south -west. This is most bought by insiders on a dollar basis, with one buyer, in this case, the director who makes one large purchase. The director and former CEO of FIRSTSUN Mollie H. Carter acquired more than $ 1 million for a little more than $ 38 million, which led to the total level of ownership of an insider and the main shareholder of more than 37%. Similarly, institutions were bought in the first quarter and March of 2025, owning another 37% of the shares.

Among the catalysts for the purchase are the deep cost and prospects of cash flows. After an unsuccessful merger, the promotions are traded at a discount on their peers and a historical range, offering significant potential allocated by analysts. FIRSTSUN analysts are optimistic, evaluating the consensus of purchases with a growth potential of 20%. The last coating includes the recently initiated coating of Matthew Clark Piper Sandler and a confirmed rating from Keefe, Bruyette and Woods. Both are supplied with target price targets.

Companies in this article:

Experience

Thomas Hughes has been a writer for Insidertrades.com since 2019.

Areas of experience

Technical analysis, S&P 500; Retail trade, consumers, consumer products, dividends, highly profitable, small restrictions, technologies, economic data, oil, cryptocurrencies

Education

Associated art in the field of culinary technology

Past experience

Market observer, trader and investor for numerous websites. LLC “Passive Market Intelligence” to provide information about market research.